Sinovac Biotech (SVA) Falls On Reports of China Vaccine Deaths
Tweet
Share
E-mailGet Alerts SVA Hot Sheet
Join SI Premium – FREE
Shares of Sinovac Biotech Ltd. (NYSE: SVA) have fallen 6% mid-day on reports of two deaths in China after patients received the H1N1 vaccine.
Preliminary findings indicated that deaths of the two adults were not linked to the vaccine. As of November 12, China has vaccinated more than 12 million people.
Preliminary findings indicated that deaths of the two adults were not linked to the vaccine. As of November 12, China has vaccinated more than 12 million people.
You May Also Be Interested In
Create E-mail Alert Related Categories
Insiders' BlogSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
